Membranolytic Activity Profile of Nonyl 3,4-Dihydroxybenzoate: A New Anti-Biofilm Compound for the Treatment of Dermatophytosis

The ability of dermatophytes to live in communities and resist antifungal drugs may explain treatment recurrence, especially in onychomycosis. Therefore, new molecules with reduced toxicity that target dermatophyte biofilms should be investigated. This study evaluated nonyl 3,4-dihydroxybenzoate (no...

Full description

Bibliographic Details
Main Authors: Caroline B. Costa-Orlandi, Níura M. Bila, Jean Lucas C. Bonatti, Carolina O. Vaso, Mariana B. Santos, Carlos R. Polaquini, Mariana M. Santoni Biasioli, Rondinelli D. Herculano, Luis O. Regasini, Ana Marisa Fusco-Almeida, Maria José S. Mendes-Giannini
Format: Article
Language:English
Published: MDPI AG 2023-05-01
Series:Pharmaceutics
Subjects:
Online Access:https://www.mdpi.com/1999-4923/15/5/1402
_version_ 1827740439553245184
author Caroline B. Costa-Orlandi
Níura M. Bila
Jean Lucas C. Bonatti
Carolina O. Vaso
Mariana B. Santos
Carlos R. Polaquini
Mariana M. Santoni Biasioli
Rondinelli D. Herculano
Luis O. Regasini
Ana Marisa Fusco-Almeida
Maria José S. Mendes-Giannini
author_facet Caroline B. Costa-Orlandi
Níura M. Bila
Jean Lucas C. Bonatti
Carolina O. Vaso
Mariana B. Santos
Carlos R. Polaquini
Mariana M. Santoni Biasioli
Rondinelli D. Herculano
Luis O. Regasini
Ana Marisa Fusco-Almeida
Maria José S. Mendes-Giannini
author_sort Caroline B. Costa-Orlandi
collection DOAJ
description The ability of dermatophytes to live in communities and resist antifungal drugs may explain treatment recurrence, especially in onychomycosis. Therefore, new molecules with reduced toxicity that target dermatophyte biofilms should be investigated. This study evaluated nonyl 3,4-dihydroxybenzoate (nonyl) susceptibility and mechanism of action on planktonic cells and biofilms of <i>T. rubrum</i> and <i>T. mentagrophytes</i>. Metabolic activities, ergosterol, and reactive oxygen species (ROS) were quantified, and the expression of genes encoding ergosterol was determined by real-time PCR. The effects on the biofilm structure were visualized using confocal electron microscopy, scanning electron microscopy (SEM), and transmission electron microscopy (TEM). <i>T. rubrum</i> and <i>T. mentagrophytes</i> biofilms were susceptible to nonyl and resistant to fluconazole, griseofulvin (all strains), and terbinafine (two strains). The SEM results revealed that nonyl groups seriously damaged the biofilms, whereas synthetic drugs caused little or no damage and, in some cases, stimulated the development of resistance structures. Confocal microscopy showed a drastic reduction in biofilm thickness, and transmission electron microscopy results indicated that the compound promoted the derangement and formation of pores in the plasma membrane. Biochemical and molecular assays indicated that fungal membrane ergosterol is a nonyl target. These findings show that nonyl 3,4-dihydroxybenzoate is a promising antifungal compound.
first_indexed 2024-03-11T03:24:57Z
format Article
id doaj.art-fe8a1dcf3ccb44f9928dd22deb32b1b4
institution Directory Open Access Journal
issn 1999-4923
language English
last_indexed 2024-03-11T03:24:57Z
publishDate 2023-05-01
publisher MDPI AG
record_format Article
series Pharmaceutics
spelling doaj.art-fe8a1dcf3ccb44f9928dd22deb32b1b42023-11-18T02:51:04ZengMDPI AGPharmaceutics1999-49232023-05-01155140210.3390/pharmaceutics15051402Membranolytic Activity Profile of Nonyl 3,4-Dihydroxybenzoate: A New Anti-Biofilm Compound for the Treatment of DermatophytosisCaroline B. Costa-Orlandi0Níura M. Bila1Jean Lucas C. Bonatti2Carolina O. Vaso3Mariana B. Santos4Carlos R. Polaquini5Mariana M. Santoni Biasioli6Rondinelli D. Herculano7Luis O. Regasini8Ana Marisa Fusco-Almeida9Maria José S. Mendes-Giannini10Department of Clinical Analysis, School of Pharmaceutical Sciences, São Paulo State University (U.N.E.S.P.), Araraquara 14800-903, SP, BrazilDepartment of Clinical Analysis, School of Pharmaceutical Sciences, São Paulo State University (U.N.E.S.P.), Araraquara 14800-903, SP, BrazilDepartment of Clinical Analysis, School of Pharmaceutical Sciences, São Paulo State University (U.N.E.S.P.), Araraquara 14800-903, SP, BrazilDepartment of Clinical Analysis, School of Pharmaceutical Sciences, São Paulo State University (U.N.E.S.P.), Araraquara 14800-903, SP, BrazilDepartment of Chemistry and Environmental Sciences, Institute of Biosciences, Humanities and Exact Sciences, São Paulo State University (U.N.E.S.P.), Sao Jose do Rio Preto 15054-000, SP, BrazilDepartment of Chemistry and Environmental Sciences, Institute of Biosciences, Humanities and Exact Sciences, São Paulo State University (U.N.E.S.P.), Sao Jose do Rio Preto 15054-000, SP, BrazilDepartment of Biological Sciences, School of Pharmaceutical Sciences, São Paulo State University (U.N.E.S.P.), Araraquara 14800-903, SP, BrazilDepartment of Bioprocesses and Biotechnology, School of Pharmaceutical Sciences, São Paulo State University (U.N.E.S.P.), Araraquara 14800-903, SP, BrazilDepartment of Chemistry and Environmental Sciences, Institute of Biosciences, Humanities and Exact Sciences, São Paulo State University (U.N.E.S.P.), Sao Jose do Rio Preto 15054-000, SP, BrazilDepartment of Clinical Analysis, School of Pharmaceutical Sciences, São Paulo State University (U.N.E.S.P.), Araraquara 14800-903, SP, BrazilDepartment of Clinical Analysis, School of Pharmaceutical Sciences, São Paulo State University (U.N.E.S.P.), Araraquara 14800-903, SP, BrazilThe ability of dermatophytes to live in communities and resist antifungal drugs may explain treatment recurrence, especially in onychomycosis. Therefore, new molecules with reduced toxicity that target dermatophyte biofilms should be investigated. This study evaluated nonyl 3,4-dihydroxybenzoate (nonyl) susceptibility and mechanism of action on planktonic cells and biofilms of <i>T. rubrum</i> and <i>T. mentagrophytes</i>. Metabolic activities, ergosterol, and reactive oxygen species (ROS) were quantified, and the expression of genes encoding ergosterol was determined by real-time PCR. The effects on the biofilm structure were visualized using confocal electron microscopy, scanning electron microscopy (SEM), and transmission electron microscopy (TEM). <i>T. rubrum</i> and <i>T. mentagrophytes</i> biofilms were susceptible to nonyl and resistant to fluconazole, griseofulvin (all strains), and terbinafine (two strains). The SEM results revealed that nonyl groups seriously damaged the biofilms, whereas synthetic drugs caused little or no damage and, in some cases, stimulated the development of resistance structures. Confocal microscopy showed a drastic reduction in biofilm thickness, and transmission electron microscopy results indicated that the compound promoted the derangement and formation of pores in the plasma membrane. Biochemical and molecular assays indicated that fungal membrane ergosterol is a nonyl target. These findings show that nonyl 3,4-dihydroxybenzoate is a promising antifungal compound.https://www.mdpi.com/1999-4923/15/5/1402dermatophytesbiofilmsanti-biofilm activityantifungal drugsmechanism of actionRT-PCR
spellingShingle Caroline B. Costa-Orlandi
Níura M. Bila
Jean Lucas C. Bonatti
Carolina O. Vaso
Mariana B. Santos
Carlos R. Polaquini
Mariana M. Santoni Biasioli
Rondinelli D. Herculano
Luis O. Regasini
Ana Marisa Fusco-Almeida
Maria José S. Mendes-Giannini
Membranolytic Activity Profile of Nonyl 3,4-Dihydroxybenzoate: A New Anti-Biofilm Compound for the Treatment of Dermatophytosis
Pharmaceutics
dermatophytes
biofilms
anti-biofilm activity
antifungal drugs
mechanism of action
RT-PCR
title Membranolytic Activity Profile of Nonyl 3,4-Dihydroxybenzoate: A New Anti-Biofilm Compound for the Treatment of Dermatophytosis
title_full Membranolytic Activity Profile of Nonyl 3,4-Dihydroxybenzoate: A New Anti-Biofilm Compound for the Treatment of Dermatophytosis
title_fullStr Membranolytic Activity Profile of Nonyl 3,4-Dihydroxybenzoate: A New Anti-Biofilm Compound for the Treatment of Dermatophytosis
title_full_unstemmed Membranolytic Activity Profile of Nonyl 3,4-Dihydroxybenzoate: A New Anti-Biofilm Compound for the Treatment of Dermatophytosis
title_short Membranolytic Activity Profile of Nonyl 3,4-Dihydroxybenzoate: A New Anti-Biofilm Compound for the Treatment of Dermatophytosis
title_sort membranolytic activity profile of nonyl 3 4 dihydroxybenzoate a new anti biofilm compound for the treatment of dermatophytosis
topic dermatophytes
biofilms
anti-biofilm activity
antifungal drugs
mechanism of action
RT-PCR
url https://www.mdpi.com/1999-4923/15/5/1402
work_keys_str_mv AT carolinebcostaorlandi membranolyticactivityprofileofnonyl34dihydroxybenzoateanewantibiofilmcompoundforthetreatmentofdermatophytosis
AT niurambila membranolyticactivityprofileofnonyl34dihydroxybenzoateanewantibiofilmcompoundforthetreatmentofdermatophytosis
AT jeanlucascbonatti membranolyticactivityprofileofnonyl34dihydroxybenzoateanewantibiofilmcompoundforthetreatmentofdermatophytosis
AT carolinaovaso membranolyticactivityprofileofnonyl34dihydroxybenzoateanewantibiofilmcompoundforthetreatmentofdermatophytosis
AT marianabsantos membranolyticactivityprofileofnonyl34dihydroxybenzoateanewantibiofilmcompoundforthetreatmentofdermatophytosis
AT carlosrpolaquini membranolyticactivityprofileofnonyl34dihydroxybenzoateanewantibiofilmcompoundforthetreatmentofdermatophytosis
AT marianamsantonibiasioli membranolyticactivityprofileofnonyl34dihydroxybenzoateanewantibiofilmcompoundforthetreatmentofdermatophytosis
AT rondinellidherculano membranolyticactivityprofileofnonyl34dihydroxybenzoateanewantibiofilmcompoundforthetreatmentofdermatophytosis
AT luisoregasini membranolyticactivityprofileofnonyl34dihydroxybenzoateanewantibiofilmcompoundforthetreatmentofdermatophytosis
AT anamarisafuscoalmeida membranolyticactivityprofileofnonyl34dihydroxybenzoateanewantibiofilmcompoundforthetreatmentofdermatophytosis
AT mariajosesmendesgiannini membranolyticactivityprofileofnonyl34dihydroxybenzoateanewantibiofilmcompoundforthetreatmentofdermatophytosis